Conatumumab clinical trials
Also written AMG 655.
- studies test it
- 10
- open now
- 0
- in phase 3
- 0
- first study started
- 2007
How each study uses conatumumab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
9 studies that test it; most in 2007 (3)
| Year | Studies |
|---|---|
| 2007 | 3 |
| 2008 | 2 |
| 2009 | 2 |
| 2011 | 1 |
| 2013 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 9 · Other 1
Amgen (5) · NantCell, Inc. (3) · TetraLogic Pharmaceuticals (1) · Radiation Therapy Oncology Group (1)
Often tested with
Tested in the same studies.
Ganitumab (4) · Birinapant (1) · Capecitabine (1) · Gemcitabine (1)
Studies
Open first, then newest update. How each study uses conatumumab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 10
- QUILT-2.019: A Study of AMG 655 or AMG 479 in Combination With Gemcitabine for Treatment of Metastatic Pancreatic CancerCompletedPhase 1/2NantCell, Inc.NCT00630552Written as AMG 655
- QUILT-3.026: AMG 655 in Combination With AMG 479 in Advanced, Refractory Solid TumorsTerminatedPhase 1/2NantCell, Inc.NCT00819169Written as AMG 655
- Open Label Extension Study of Conatumumab and Ganitumab (AMG 479)CompletedPhase 2AmgenNCT01327612Written as Conatumumab
- QUILT-2.018: Safety & Efficacy of FOLFIRI With AMG 479 or AMG 655 vs FOLFIRI Alone in KRAS-mutant Metastatic Colorectal CarcinomaCompletedPhase 2NantCell, Inc.NCT00813605Written as AMG 655
- A Phase 1b/2 Study of AMG 655 in Combination With Paclitaxel and Carboplatin for the First-Line Treatment of Advanced Non-Small Cell Lung CancerCompletedPhase 1/2AmgenNCT00534027Written as AMG 655
- Study of Birinapant in Combination With Conatumumab in Subjects With Relapsed Ovarian CancerCompletedPhase 1TetraLogic PharmaceuticalsNCT01940172Written as Conatumumab
- Phase 1b/2 Study of AMG 655 With Doxorubicin for the First-Line Treatment of Unresectable Soft Tissue SarcomaCompletedPhase 1/2AmgenNCT00626704Written as AMG 655
- Phase 1b/2 Study of AMG 655 With mFOLFOX6 and Bevacizumab for First-Line Metastatic Colorectal CancerCompletedPhase 1/2AmgenNCT00625651Written as AMG 655
- Conatumumab/Panitumumab Combination Metastatic Colorectal Cancer StudyCompletedPhase 1/2AmgenNCT00630786Written as Conatumumab
- Conatumumab, Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic CancerWithdrawnPhase 1/2Radiation Therapy Oncology GroupNCT01017822Written as conatumumab
Given beside what is tested · 1 — conatumumab is usual care or a partner of the new treatment
Codes
What other systems call conatumumab · ClinicalTrials.gg INT005753
- MeSH (NLM) C554537conatumumabConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 1P48L61KM0CONATUMUMABConfirmed FDA, NLM, Wikidata
- Wikidata Q3685951conatumumabConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C71015ConatumumabOne source FDA
- DrugBank DB11646One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C554537 | conatumumab | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 1P48L61KM0 | CONATUMUMAB | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q3685951 | conatumumab | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C71015 | Conatumumab | One source FDA |
| DrugBank | DB11646 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.